Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
TRLV
STRONG BUYTrulieve Cannabis Corp. · Healthcare · United States · $1.6B · Avg Vol: $13M/d
87
StockRankGet insider-trade alerts
Q
60
V
66
M
58
P/E (TTM)
—
ROE
-6.9%
D/E
0.5x
Dividend %
—
Loading 1Y...
PRICE (1Y)-19.5%
SMA 50SMA 200
Close
$8.33
RSI (14)
38.6
52W High
$13.28
From 52W High
0.6%
SCORE BREAKDOWN
Quality
60
ROIC
6.1%61.5
ROE
-6.9%39.0
GP/Assets
25.9%59.4
Op. Margin
12.4%71.2
FCF/Assets
8.3%82.0
Piotroski
376.1
Int. Cover
2.6x45.3
D/E Ratio
0.55x28.3
Current Ratio
5.26x72.3
Value
66
P/E (TTM)
—N/A
EV/EBITDA
5.8x89.0
P/FCF
7.2x88.7
P/B
1.4x74.5
P/S
1.4x76.9
Div Yield
—N/A
Momentum
58
52W High %
63%43.2
RS 6M
-11%59.5
SMA 50/200
1.19x88.7
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+160%84.8
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$1.6B
P/E (Forward)
34.9x
Gross Margin
59.7%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TRLV are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| TRLV | Trulieve Cannabis Corp.(you) | $1.6B | 87 | STRONG BUY |
| GTII.CN | Green Thumb Industries Inc. | $1.6B | 93 | STRONG BUY |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.4B | 88 | STRONG BUY |
| ANIP | ANI Pharmaceuticals, Inc. | $1.8B | 97 | STRONG BUY |
| PBH | Prestige Consumer Healthcare Inc. | $2.4B | 82 | STRONG BUY |
| COLL | Collegium Pharmaceutical, Inc. | $1.1B | 95 | STRONG BUY |
| PAHC | Phibro Animal Health Corporation | $1.4B | 76 | BUY |
| PCRX | Pacira BioSciences, Inc. | $1.0B | 93 | STRONG BUY |
| INDV | Indivior Pharmaceuticals, Inc. | $4.8B | 91 | STRONG BUY |
| AMRX | Amneal Pharmaceuticals, Inc. | $5.7B | 87 | STRONG BUY |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%